US4170590A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ion exchanger treatment of citrate-stabilized plasma
Assignee: Biotest Serum Institut GmbH
•
Filing: 1978-02-06
•
Granted: 1979-10-09
•
Expires: 1998-02-06
Abstract
Abstract A citrate-stabilized blood plasma is frozen and thawed, the undissolved cryoprecipitate is separated and is rich in factor VIII protein. The residual liquid is treated with cation and anion exchangers, either sequentially or in admixture, to separate calcium and citrate ions therefrom. The residual plasma is then subjected to adsorption to remove a fraction which is eluted and precipitated, enriched in factors II, VII, IX and X. The liquid left from adsorption is subjected to further adsorption with silicic acid, leaving a storage-stable serum. The silicic acid is eluted to dissolve adsorbed fibrinogen which then is re-precipitated.
Inventors
- 👤 Wolfgang Stephan
- 👤 Ronald Kotitschke
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:29
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6429; C07; C07K; C07K14/00; C07K14/435; C07K14/745; C07K14/755; C12Y; C12Y304/00; C12Y304/21; C12Y304/21005; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
175 words
In the fractionation of blood comprising the steps of taking blood from a donor, separating the solids from the plasma, freezing the plasma, thawing the frozen plasma and separating from the thawed plasma fluid a first product comprising undissolved cryoprecipitate enriched in factor-VIII protein; dissolving the first product, removing impurities from the solution of the first product, precipitating the factor-VIII protein from the solution; after separation of the first product treating the residual thawed plasma fluid with a solid adsorbent thereby to adsorb the factors II, VII, IX and X, and separating a second product comprising solid adsorbent and the adsorbed factors from the residual plasma; and, after separation of the second product, contacting the residual plasma with colloidal silica and separating a third product comprising a storage-stable serum protein solution from the colloidal silica, the improvement which comprises mixing the blood or plasma with a citrate stabilizer prior to freezing and treating the residual thawed plasma fluid with an anion exchange resin and a cation exchange resin prior to treatment with the solid adsorbent.
Claim 2
Dependent Claim
175 words
In the fractionation of blood comprising the steps of taking blood from a donor, separating the solids from the plasma, freezing the plasma, thawing the frozen plasma and separating from the thawed plasma fluid a first product comprising undissolved cryoprecipitate enriched in factor-VIII protein; dissolving the first product, removing impurities from the solution of the first product, precipitating the factor-VIII protein from the solution; after separation of the first product treating the residual thawed plasma fluid with a solid adsorbent thereby to adsorb the factors II, VII, IX and X, and separating a second product comprising solid adsorbent and the adsorbed factors from the residual plasma; and, after separation of the second product, contacting the residual plasma with colloidal silica and separating a third product comprising a storage-stable serum protein solution from the colloidal silica, the improvement which comprises mixing the blood or plasma with a citrate stabilizer prior to freezing and treating the residual thawed plasma fluid with an anion exchange resin and a cation exchange resin prior to treatment with the solid adsorbent.
Claim 3
Dependent Claim
39 words
A process according to claim 1, including the further steps of extracting the colloidal silica separated from the storage-stable serum protein solution with a solvent solution to dissolve fibrinogen, and then adding to said solution a precipitant for fibrinogen.
Claim 4
Dependent Claim
15 words
A process according to claim 1, wherein the anion and cation exchangers are mixed together.
Claim 5
Dependent Claim
16 words
A process according to claim 1, wherein the anion and cation exchangers successively contact the plasma.
Claim 6
Dependent Claim
18 words
A process according to claim 1, wherein the cation exchanger is initially in the sodium or hydrogen form.
Claim 7
Dependent Claim
18 words
A process according to claim 1, wherein the anion exchanger is initially in the chloride or hydroxide form.
Claim 8
Dependent Claim
30 words
A process according to claim 2, wherein the cation exchanger is initially in the sodium or hydrogen form, and the anion exchanger is initially in the chloride or hydroxide form.
References Cited (Backward Citations)
US3652530A
Cited
US3916026A
Cited
US3682881A
Cited
US3869436A
Cited
US3920625A
Cited
US3973002A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-10-08 | 1983-04-09 | 1983-10-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-10-08 | 1987-04-09 | 1987-10-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-10-08 | 1991-04-09 | 1991-10-09 | $7700.00 | Window Closed / Lapsed |